BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27322606)

  • 21. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
    Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
    J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic healthcare costs of Clostridium difficile infection: a systematic review.
    Ghantoji SS; Sail K; Lairson DR; DuPont HL; Garey KW
    J Hosp Infect; 2010 Apr; 74(4):309-18. PubMed ID: 20153547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
    Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC
    BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile-related hospitalizations and risk factors for in-hospital mortality in Spain between 2001 and 2015.
    Esteban-Vasallo MD; de Miguel-Díez J; López-de-Andrés A; Hernández-Barrera V; Jiménez-García R
    J Hosp Infect; 2019 Jun; 102(2):148-156. PubMed ID: 30240814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.
    Tabak YP; Zilberberg MD; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
    Cassini A; Plachouras D; Eckmanns T; Abu Sin M; Blank HP; Ducomble T; Haller S; Harder T; Klingeberg A; Sixtensson M; Velasco E; Weiß B; Kramarz P; Monnet DL; Kretzschmar ME; Suetens C
    PLoS Med; 2016 Oct; 13(10):e1002150. PubMed ID: 27755545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
    Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW
    J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study.
    Daneman N; Guttmann A; Wang X; Ma X; Gibson D; Stukel TA
    BMJ Qual Saf; 2015 Jul; 24(7):435-43. PubMed ID: 25911052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The direct healthcare costs attributable to West Nile virus illness in Ontario, Canada: a population-based cohort study using laboratory and health administrative data.
    Shing E; Wang J; Nelder MP; Parpia C; Gubbay JB; Loeb M; Kristjanson E; Marchand-Austin A; Moore S; Russell C; Sider D; Sander B
    BMC Infect Dis; 2019 Dec; 19(1):1059. PubMed ID: 31847823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study.
    Asensio A; Di Bella S; Lo Vecchio A; Grau S; Hart WM; Isidoro B; Scotto R; Petrosillo N; Watt M; Nazir J
    Int J Infect Dis; 2015 Jul; 36():31-8. PubMed ID: 26003403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
    Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
    J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
    Lambert PJ; Dyck M; Thompson LH; Hammond GW
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.
    Sammons JS; Localio R; Xiao R; Coffin SE; Zaoutis T
    Clin Infect Dis; 2013 Jul; 57(1):1-8. PubMed ID: 23532470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of Clostridium difficile in surgical patients in the United States.
    Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
    Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection.
    Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S
    J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.
    Zhang S; Palazuelos-Munoz S; Balsells EM; Nair H; Chit A; Kyaw MH
    BMC Infect Dis; 2016 Aug; 16(1):447. PubMed ID: 27562241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
    Olsen MA; Young-Xu Y; Stwalley D; Kelly CP; Gerding DN; Saeed MJ; Mahé C; Dubberke ER
    BMC Infect Dis; 2016 Apr; 16():177. PubMed ID: 27102582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
    Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
    Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital-acquired lower respiratory tract infections among high risk hospitalized patients in a tertiary care teaching hospital in China: An economic burden analysis.
    Yan T; Li Y; Sun Y; Wang H; Wang J; Wang W; Liu Y; Wu X; Wang S
    J Infect Public Health; 2018; 11(4):507-513. PubMed ID: 29113779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study.
    Antunes A; Tricotel A; Wilk A; Dombrowski S; Rinta-Kokko H; Andersson FL; Ghosh S
    BMC Infect Dis; 2024 May; 24(1):548. PubMed ID: 38822244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.